Saxol to Participate in BioEquity Europe 2025 in Bruges
Saxol is pleased to announce its participation in BioEquity Europe 2025, taking place from May 12-14 in Bruges. Celebrating its 25th year, BioEquity Europe is the premier event for biopharma decision-makers, attracting more venture capitalists than any other biotech conference.
This year’s central theme, “Biotech’s Complex Moment: What’s Next for Europe?”, will explore the increasing complexity of the biotech landscape. As companies seek to source Asian assets for Western markets while navigating geopolitical tensions, challenges around globalization, data sharing, and cross-border talent exchange have never been more pressing.
Representing Saxol at the event, Ph. Bordeau will engage with investors, industry leaders, and key stakeholders to discuss the evolving biotech ecosystem in Europe. The event provides a unique opportunity to connect with potential partners, explore investment opportunities, and contribute to the broader conversation about the future of European biotech in a rapidly changing global environment.
As Saxol continues to develop innovative solutions in oncology, participating in BioEquity Europe aligns with our mission to foster strategic collaborations and drive progress in the biopharma sector.
If you’re attending BioEquity Europe and would like to connect with Saxol, feel free to reach out!
